or Try an Advanced Search...

    Technical Analysis for CMND - Clearmind Medicine Inc.

    Grade Last Price % Change Price Change
    D 1.34 0.75% 0.01
    CMND closed up 0.75 percent on Tuesday, November 19, 2024, on 13 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CMND trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    200 DMA Resistance Bearish 0.75%
    50 DMA Resistance Bearish 0.75%
    NR7 Range Contraction 0.75%
    Gapped Up Strength 0.75%
    Older End-of-Day Signals for CMND ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 17 hours ago
    Possible NR7 about 17 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    200 DMA Resistance 1 day ago
    Reversed from Up 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CMND Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.
    Classification
    Keywords: Biotechnology Health Sciences Medication

    Is CMND a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 10 Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
    Sep 16 Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
    Sep 12 Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
    Sep 6 SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
    Sep 6 Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
    Aug 29 Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
    Aug 25 Weekly Roundup on the Cannabis Sector & Psychedelic Sector
    Aug 21 Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
    Aug 16 Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
    Aug 9 Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
    See more CMND news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.8
    52 Week Low 0.9205
    Average Volume 313,262
    200-Day Moving Average 1.35
    50-Day Moving Average 1.37
    20-Day Moving Average 1.43
    10-Day Moving Average 1.43
    Average True Range 0.12
    RSI (14) 44.75
    ADX 22.37
    +DI 17.60
    -DI 16.40
    Chandelier Exit (Long, 3 ATRs) 1.43
    Chandelier Exit (Short, 3 ATRs) 1.66
    Upper Bollinger Bands 1.57
    Lower Bollinger Band 1.29
    Percent B (%b) 0.17
    BandWidth 19.62
    MACD Line 0.00
    MACD Signal Line 0.02
    MACD Histogram -0.0181
    Fundamentals Value
    Market Cap 4.25 Million
    Num Shares 3.17 Million
    EPS -31.63
    Price-to-Earnings (P/E) Ratio -0.04
    Price-to-Sales 0.00
    Price-to-Book 6.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.39
    Resistance 3 (R3) 1.39 1.37 1.38
    Resistance 2 (R2) 1.37 1.35 1.37 1.38
    Resistance 1 (R1) 1.35 1.35 1.36 1.36 1.38
    Pivot Point 1.33 1.33 1.34 1.33 1.33
    Support 1 (S1) 1.32 1.32 1.33 1.32 1.30
    Support 2 (S2) 1.30 1.31 1.30 1.30
    Support 3 (S3) 1.28 1.30 1.30
    Support 4 (S4) 1.29